In his clinic as a third-year fellow at Johns Hopkins Hospital in Baltimore, Ethan Craig, MD, MHS, says it’s not always easy to hear about patients struggling with step therapy or other barriers to treatment. However, as a member of the ACR’s Government Affairs Committee (GAC), he says his work to understand and improve policy that affects patients living with rheumatic conditions gives him the ability to talk to his patients about what he is doing to help.
You Might Also Like
- Bringing a Public & Private Practice Perspective to the ACR: A conversation with CORC Chair Colin Edgerton, MD, FACP, RhMSUS
- Protecting Patient Care on All Fronts: A Conversation with Kent “Kwas” Huston, MD, ACR Government Affairs Committee Member
- Connect Rheumatology: A Conversation with Paul Sufka, MD, ACR Committee on Marketing & Communications Member
Also By This Author
“I can honestly tell my patients I am doing everything I can to address these challenges for them,” Dr. Craig shares. He says his work on the policy side of rheumatology through volunteering with the GAC is also helping him understand the landscape of rheumatology practice as he looks ahead at his career.
Dr. Craig came to rheumatology almost by accident. His initial career path was in infectious disease; however, a chance assignment to a rheumatology rotation with his “phenomenal” mentor, Elie Gertner, MD, helped him realize his path was firmly grounded in rheumatology practice.
Dr. Craig was also encouraged to get involved with the ACR early on as a chief resident in 2015, a move that influenced his work in advocacy when he participated in an ACR advocacy day in Washington, D.C.
“I was thrilled to have a direct audience with my congressman to advocate for my profession and get a firsthand look at advocacy in action,” Dr. Craig says.
With this perspective on the value of advocacy for rheumatology, he was inspired to get more involved in influencing policy, and so applied and was accepted as a member of the ACR’s GAC.
Gaining Policy Perspective
Dr. Craig describes his work with the GAC this year as “eye-opening” when it comes to aspects of clinical practice influenced by policy. “Before learning about them from the GAC, I had never thought about MIPS, APMs, MACRA, how Part B drugs are reimbursed, or the roles of PBMs [pharmacy benefit managers] in drug prices,” he shares. “As fellows, we tend to be somewhat sheltered from some of these realities.”
He has also witnessed the important successes the GAC has achieved for patients and physicians, such as repealed caps on physical therapy coverage, positive changes for patient access to Part B therapies, and a much greater awareness and transparency on the topic of PBMs.
His own contributions to updating the ACR’s 2018 position statements have been “an exciting opportunity to define the ACR’s policy goals for the year” and have taught Dr. Craig a tremendous amount about the inner workings of the policy landscape.